Clinical Trial Update: Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED) [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial assessing palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients undergoing m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Palonosetron (palonosetron)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Nausea | Phase 4 | Status: COMPLETED